FDA proposes a streamlined hub-and-spoke registration model for distributed manufacturing networks.
Consolidated registration pathway aims to significantly reduce administrative burdens for complex manufacturing companies.
Mandatory registration for all foreign establishments supplying components for the U.S. market.
New requirements mandate advance notification to the FDA for any manufacturing unit relocations.